FRA:MRK

MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News

€172.65

+0.40 (+0.23 %)

(As of 07/30/2021 12:00 AM ET)

Add

Compare

Today's Range

€170.25

▼

€173.50

50-Day Range

€143.35

▼

€173.95

52-Week Range

€76.60

▼

€115.00

Volume180,640 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive MRK News and Ratings via Email

Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter.

About MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.

MERCK Kommanditgesellschaft auf Aktien (FRA:MRK) Stock Price Passes Above Two Hundred Day Moving Average of $0.00
July 29, 2021 | americanbankingnews.com

MERCK Kommanditgesellschaft auf Aktien (FRA:MRK) Shares Cross Above Two Hundred Day Moving Average of $0.00
July 13, 2021 | americanbankingnews.com

MORNING BID-A tense finish
June 29, 2021 | finance.yahoo.com

Signature Resources Announces $3.5 Million Non-Brokered Private Placement LED by Commodity Discovery Fund, Funds Managed by Sprott Asset Management LP & Crescat Capital
June 21, 2021 | finance.yahoo.com

This New Product Is Central to mRNA Vaccines -- But Should You Buy the Stock?
June 9, 2021 | finance.yahoo.com

UPDATE 1-Lab supplier Merck KGaA says U.S. Defense Production Act poses challenge
May 12, 2021 | finance.yahoo.com

MORNING BID-Covid, missiles and tanker tailbacks
March 25, 2021 | finance.yahoo.com

MERCK Kommanditgesellschaft auf Aktien (MRK1N.MX)
March 11, 2021 | ca.finance.yahoo.com

Germany's Merck KGaA predicts earnings gain in 2021 on lab gear
March 4, 2021 | finance.yahoo.com

Hydrophobic Interaction Chromatography Resins Market (2020-29): Demand and Scope, Industry Trends and Threats | Tosoh Corporation, Pall Corporation
December 27, 2020 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange FRA
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolFRA:MRK
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.merckgroup.com
Phone+49-6151-720
Employees73,500
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

MarketRank^™

Overall MarketRank^™

1.05 out of 5 stars

1.1 Analyst's Opinion

Consensus Rating
MERCK Kommanditgesellschaft auf Aktien has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on 4 buy ratings, 8 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of €123.00, MERCK Kommanditgesellschaft auf Aktien has a forecasted downside of 28.8% from its current price of €172.65.
Amount of Analyst Coverage
MERCK Kommanditgesellschaft auf Aktien has received no research coverage in the past 90 days.

4.1 Community Rank

Outperform Votes
MERCK Kommanditgesellschaft auf Aktien has received 838 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
MERCK Kommanditgesellschaft auf Aktien has received 497 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
MERCK Kommanditgesellschaft auf Aktien has received 62.77% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about MERCK Kommanditgesellschaft auf Aktien and other stocks. Vote “Outperform” if you believe MRK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MRK will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
MERCK Kommanditgesellschaft auf Aktien does not currently pay a dividend.
Dividend Growth
MERCK Kommanditgesellschaft auf Aktien does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MERCK Kommanditgesellschaft auf Aktien insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

MERCK Kommanditgesellschaft auf Aktien (FRA:MRK) Frequently Asked Questions

Is MERCK Kommanditgesellschaft auf Aktien a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MERCK Kommanditgesellschaft auf Aktien in the last year. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MERCK Kommanditgesellschaft auf Aktien stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MRK, but not buy additional shares or sell existing shares.
View analyst ratings for MERCK Kommanditgesellschaft auf Aktien or view top-rated stocks.

What stocks does MarketBeat like better than MERCK Kommanditgesellschaft auf Aktien?

Wall Street analysts have given MERCK Kommanditgesellschaft auf Aktien a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MERCK Kommanditgesellschaft auf Aktien wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has MERCK Kommanditgesellschaft auf Aktien's stock price been impacted by Coronavirus (COVID-19)?

MERCK Kommanditgesellschaft auf Aktien's stock was trading at €98.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MRK shares have increased by 75.0% and is now trading at €172.65.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for MRK?

13 Wall Street analysts have issued 1 year price targets for MERCK Kommanditgesellschaft auf Aktien's shares. Their forecasts range from €102.00 to €144.00. On average, they anticipate MERCK Kommanditgesellschaft auf Aktien's share price to reach €123.00 in the next twelve months. This suggests that the stock has a possible downside of 28.8%.
View analysts' price targets for MERCK Kommanditgesellschaft auf Aktien or view top-rated stocks among Wall Street analysts.

Who are MERCK Kommanditgesellschaft auf Aktien's key executives?

MERCK Kommanditgesellschaft auf Aktien's management team includes the following people:

Ms. Belen Garijo Lopez M.D., Chair of Exec. Board & CEO (Age 61, Pay $5M)
Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 53, Pay $4.07M)
Dr. Kai Beckmann, CEO of Electronics & Member of the Exec. Board (Age 56, Pay $4.15M)
Mr. Peter Guenter, CEO of Healthcare Bus. & Member of Exec. Board (Age 59)
Dr. Matthias J. Heinzel, CEO of Life Science Sector & Member of Exec. Board (Age 55)
Mr. Gerhard Schmitz, Head of Global Accounting (Age 58)
Mr. Dirk Toepfer, Chief Information Officer
Mr. Constantin Fest, Head of Investor Relations (Age 44)
Dr. Friederike Rotsch, Group Gen. Counsel and Head of Group Legal & Compliance (Age 49)
Ms. Barbara Weiland, Chief Compliance Officer (Age 47)

Who are some of MERCK Kommanditgesellschaft auf Aktien's key competitors?

Some companies that are related to MERCK Kommanditgesellschaft auf Aktien include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF) and Charlotte's Web (CWBHF).
View all of MRK's competitors.

What other stocks do shareholders of MERCK Kommanditgesellschaft auf Aktien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MERCK Kommanditgesellschaft auf Aktien investors own include Micron Technology (MU), NVIDIA (NVDA), QUALCOMM (QCOM), Abbott Laboratories (ABT), Cisco Systems (CSCO), Gilead Sciences (GILD), Advanced Micro Devices (AMD), The Boeing (BA), CVS Health (CVS) and Eli Lilly and (LLY).

What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

MERCK Kommanditgesellschaft auf Aktien trades on the FRA under the ticker symbol "MRK."

What is MERCK Kommanditgesellschaft auf Aktien's stock price today?

One share of MRK stock can currently be purchased for approximately €172.65.

How many employees does MERCK Kommanditgesellschaft auf Aktien have?

MERCK Kommanditgesellschaft auf Aktien employs 73,500 workers across the globe.

What is MERCK Kommanditgesellschaft auf Aktien's official website?

The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com.

Where are MERCK Kommanditgesellschaft auf Aktien's headquarters?

MERCK Kommanditgesellschaft auf Aktien is headquartered at Frankfurter Strasse 250, DARMSTADT, 64293, Germany.

How can I contact MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The healthcare company can be reached via phone at +49-6151-720.

This page was last updated on 8/1/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News

About MERCK Kommanditgesellschaft auf Aktien

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

1.1 Analyst's Opinion

Consensus Rating

Price Target Upside/Downside

Amount of Analyst Coverage

4.1 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment